Skip to main content
AAPS PharmSciTech logoLink to AAPS PharmSciTech
. 2014 Mar 30;7(4):E24–E30. doi: 10.1208/pt070486

The effect of drug concentration and curing time on processing and properties of calcium alginate beads containing metronidazole by response surface methodology

Yagnesh L Patel 1,, Praveen Sher 1, Atmaram P Pawar 1,
PMCID: PMC2750323  PMID: 16584155

Abstract

The purpose of present research work was to prepare calcium alginate beads containing water-soluble drug metronidazole using 32 factorial design, with drug concentration and curing time as variables. Curing time was kept as low as possible to improve entrapment with increasing drug concentration. Mostly the drugs which had been encapsulated were water insoluble to facilitate drug encapsulation; a characteristic drug release as whole process is aqueous based. Entrapment efficiency was in the range of 81% to 96% wt/wt, which decreased with decrease in polymer concentration and increase in curing time. The beads were spherical with size range between 1.4 and 1.9 mm. Scanning electron microscope (SEM) photomicrographs revealed increase in the leaching of drug crystals with increased curing time and high drug concentrations. In acidic environment, the swelling ratio was 200% in 30 minutes, but in basic medium, it increased to a maximum of 1400% within 120 minutes. In acidic medium, the swelling and drug release properties were influenced by drug solubility, whereas in phosphate buffer these properties were governed by the gelling of polymer and exhibited curvilinear and quadratic functions of both the variables, respectively.

Keywords: calcium alginate, ionotropic gelling, water-soluble drug, curing time, metronidazole

Full Text

The Full Text of this article is available as a PDF (491.9 KB).

References

  • 1.Shilpa A, Agrawal SS, Rao AR. Controlled delivery of drugs from alginate matrix. J Macromol Sci-Polym Rev. 2003;43:187–221. doi: 10.1081/MC-120020160. [DOI] [Google Scholar]
  • 2.Draget KI, Skjak-Braek G, Smidsrod O. Alginate based new materials. Int J Biol Macromol. 1997;21:47–55. doi: 10.1016/S0141-8130(97)00040-8. [DOI] [PubMed] [Google Scholar]
  • 3.Tomida H, Mizuo C, Nakamura C, Kiryu S. Imipramine release from Ca-alginate gel beads. Chem Pharm Bull (Tokyo) 1993;41:1475–1477. doi: 10.1248/cpb.41.1475. [DOI] [Google Scholar]
  • 4.Lim LY, Wan LSC. Propranolol hydrochloride binding in calcium alginate beads. Drug Dev Ind Pharm. 1997;23:973–980. doi: 10.3109/03639049709149149. [DOI] [Google Scholar]
  • 5.Batchelor HK, Banning D, Dettmar PW, Hampson FC, Jolliffe IJ, Craig DQM. An in-vitro mucosal model for the prediction of the bioadhesion of alginate solutions to the oesophagus. Int J Pharm. 2002;238:123–132. doi: 10.1016/S0378-5173(02)00062-5. [DOI] [PubMed] [Google Scholar]
  • 6.Blandino A, Macias M, Cantero D. Glucose oxidase release from calcium alginate gel capsules. Enzyme Microb Technol. 2000;27:319–324. doi: 10.1016/S0141-0229(00)00204-0. [DOI] [PubMed] [Google Scholar]
  • 7.Bodmeier R, Paeratakul O. Spherical agglomerates of water-insoluble drugs. J Pharm Sci. 1989;78:964–967. doi: 10.1002/jps.2600781117. [DOI] [PubMed] [Google Scholar]
  • 8.Bodmeier R, Wang J. Microencapsulation of drugs with aqueous colloidal polymer dispersions. J Pharm Sci. 1993;82:191–194. doi: 10.1002/jps.2600820215. [DOI] [PubMed] [Google Scholar]
  • 9.Takka S, Ocak OH, Acarturk F. Formulation and investigation of nicardipine HCl-alginate gel beads with factorial design-based studies. Eur J Pharm Sci. 1998;6:241–246. doi: 10.1016/S0928-0987(97)10005-7. [DOI] [PubMed] [Google Scholar]
  • 10.Yotsuyanagi T, Ohkubo T, Ohhashi T, Ikeda T. Calcium-induced gelation of alginic acid and pH-sensitive reswelling of dried gels. Chem Pharm Bull (Tokyo) 1987;35:1555–1563. doi: 10.1248/cpb.35.1555. [DOI] [Google Scholar]
  • 11.Kulkarni AR, Soppimath KS, Aminabhavi TM. Controlled release of diclofenac sodium from sodium alginate beads crosslinked with glutaraldehyde. Pharm Acta Helv. 1999;74:29–36. doi: 10.1016/S0031-6865(99)00015-1. [DOI] [Google Scholar]
  • 12.Acarturk F, Takka S. Calcium alginate microparticles for oral administration. II. Effect of formulation factors on drug release and drug entrapment efficiency. J Microencapsul. 1999;16:275–290. doi: 10.1080/026520499289013. [DOI] [PubMed] [Google Scholar]
  • 13.Murata Y, Sasaki N, Miyamoto E, Kawashima S. Use of floating alginate gel beads for stomach-specific drug delivery. Eur J Pharm Biopharm. 2000;50:221–226. doi: 10.1016/S0939-6411(00)00110-7. [DOI] [PubMed] [Google Scholar]
  • 14.Efentakis M, Buckton G. The effect of erosion and swelling on the dissolution of Theophylline from low and high viscosity sodium alginate matrices. Pharm Dev Technol. 2002;7:69–77. doi: 10.1081/PDT-120002232. [DOI] [PubMed] [Google Scholar]
  • 15.Fundueanu G, Mihai D, Carpov A, Desbrieres J, Rinaudo M, Nastruzzi C. Preparation and characterization of Ca-alginate microspheres produced with different methods. Biomaterials. 1999;20:1427–1435. doi: 10.1016/S0142-9612(99)00050-2. [DOI] [PubMed] [Google Scholar]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES